Schrödinger, Inc. (SDGR)
NASDAQ: SDGR · Real-Time Price · USD
11.80
+0.50 (4.42%)
At close: Feb 25, 2026, 4:00 PM EST
11.78
-0.02 (-0.17%)
After-hours: Feb 25, 2026, 7:49 PM EST
Schrödinger Revenue
Schrödinger had revenue of $54.32M in the quarter ending September 30, 2025, with 53.94% growth. This brings the company's revenue in the last twelve months to $256.95M, up 32.90% year-over-year. In the year 2024, Schrödinger had annual revenue of $207.54M, down -4.21%.
Revenue (ttm)
$256.95M
Revenue Growth
+32.90%
P/S Ratio
3.40
Revenue / Employee
$287,171
Employees
891
Market Cap
869.24M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 207.54M | -9.13M | -4.21% |
| Dec 31, 2023 | 216.67M | 35.71M | 19.73% |
| Dec 31, 2022 | 180.96M | 43.02M | 31.19% |
| Dec 31, 2021 | 137.93M | 29.84M | 27.60% |
| Dec 31, 2020 | 108.10M | 22.55M | 26.36% |
| Dec 31, 2019 | 85.54M | 18.90M | 28.37% |
| Dec 31, 2018 | 66.64M | 10.95M | 19.65% |
| Dec 31, 2017 | 55.69M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teladoc Health | 2.53B |
| Evolent Health | 1.88B |
| Omnicell | 1.18B |
| GoodRx Holdings | 800.65M |
| Phreesia | 463.21M |
| Certara | 415.55M |
| HealthStream | 304.06M |
| Weave Communications | 239.02M |
SDGR News
- 4 hours ago - Schrödinger, Inc. (SDGR) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 9 hours ago - Schrödinger Reports Fourth Quarter and Full-Year 2025 Financial Results - Business Wire
- 1 day ago - Schrödinger to Participate in Upcoming Investor Conferences - Business Wire
- 6 days ago - Top 3 Health Care stocks That Could Lead To Your Biggest Gains In Q1 - Benzinga
- 7 days ago - Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 14 days ago - Schrödinger to Announce Fourth Quarter and Full-Year 2025 Financial Results on February 25 - Business Wire
- 6 weeks ago - Schrödinger Provides Update on Progress Across the Business and Outlines 2026 Strategic Priorities - Business Wire
- 6 weeks ago - Schrodinger to offer Eli Lilly's AI drug discovery platform on its software - Reuters